Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 2 (1)

Trial Status

Unknown2
Recruiting1
Terminated1

Clinical Trials (4)

Showing 4 of 4 trials
NCT02872532Not ApplicableRecruiting

Testicular Tissue Cryopreservation in Children

NCT02970500Phase 2Terminated

Effect of Methylphenidate on Cancer-related Cognitive Impairment

NCT04843657UnknownPrimary

Precise Care for Cancer Related Fatigue

NCT04300842UnknownPrimary

Quantifying Fatigue in Cancer Patients Using Smart Bracelet Devices

Showing all 4 trials

Research Network

Activity Timeline